(VIANEWS) – NEOEN (NEOEN.PA), AKER SOLUTIONS (AKSO.OL), MELHUS SPAREBANK (MELG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NEOEN (NEOEN.PA)
48.5% sales growth and 7.39% return on equity
Neoen S.A., an independent renewable energy production company, engages in the development and operation of renewable energy power plants. The company operates through Solar Power, Wind Power, Storage, Farm-Down, Development and Investments, and Eliminations segments. It operates in Argentina, Australia, Canada, Ecuador, the United States, Finland, France, Ireland, Italy, Jamaica, Mexico, Mozambique, Portugal, El Salvador, Sweden, and Zambia. Neoen S.A. was incorporated in 2008 and is headquartered in Paris, France. Neoen S.A. operates as a subsidiary of Impala SAS.
Earnings Per Share
As for profitability, NEOEN has a trailing twelve months EPS of €1.14.
PE Ratio
NEOEN has a trailing twelve months price to earnings ratio of 26.21. Meaning, the purchaser of the share is investing €26.21 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.39%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.6%, now sitting on 556.1M for the twelve trailing months.
Sales Growth
NEOEN’s sales growth is 63.4% for the present quarter and 48.5% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 0.13 and the estimated forward annual dividend yield is 0.42%.
Yearly Top and Bottom Value
NEOEN’s stock is valued at €29.88 at 21:20 EST, way under its 52-week high of €39.50 and way higher than its 52-week low of €23.04.
More news about NEOEN.
2. AKER SOLUTIONS (AKSO.OL)
16.8% sales growth and 17.09% return on equity
Aker Solutions ASA provides solutions, products, systems, and services to the oil and gas industry worldwide. It offers field planning, feasibility, and concept studies; specialist engineering, project management, and procurement services; floater designs, offshore wind, as well as engages in design, delivery, and construction of deep-water risers, oil, and gas production, and receiving and processing facilities. In addition, the company provides offshore fish farming, carbon capture, utilization and storage, hydrogen, and offshore wind solutions. Further, the company designs and constructs jackets for construction services and offers electrification services; and designs and constructs offshore oil and gas production facilities and onshore receiving and processing facilities. Additionally, the company provides subsea production, compression, pump, power distribution, and processing systems, and subsea lifecycle services. Furthermore, the company offers maintenance, modifications, decommissioning, asset integrity management, hook-up, and completion solutions. Aker Solutions ASA was founded in 1841 and is headquartered in Fornebu, Norway.
Earnings Per Share
As for profitability, AKER SOLUTIONS has a trailing twelve months EPS of kr3.41.
PE Ratio
AKER SOLUTIONS has a trailing twelve months price to earnings ratio of 12.34. Meaning, the purchaser of the share is investing kr12.34 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.09%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 48.05B for the twelve trailing months.
Volume
Today’s last reported volume for AKER SOLUTIONS is 293616 which is 62.62% below its average volume of 785526.
More news about AKER SOLUTIONS.
3. MELHUS SPAREBANK (MELG.OL)
15.6% sales growth and 10.56% return on equity
Melhus Sparebank, a savings bank, provides various banking products and services to companies, agriculture customers, and private individuals in Norway. The company offers savings accounts; construction and business loans; mortgage, and car loans; bank guarantee, overdraft, and leasing services; and credit and bank cards. It also provides various insurance products for home, cottage, household goods, contents, drone, car, boat, other vehicles, travel, animal, children, death, health, critical illness, disabled, private, commercial, agricultural, and accident; savings and pension products; payment services; and online and mobile banking services. The company operates through branch offices in central Trondheim, Heimdal, Ler, and Korsvegen. Melhus Sparebank was founded in 1840 and is headquartered in Melhus, Norway.
Earnings Per Share
As for profitability, MELHUS SPAREBANK has a trailing twelve months EPS of kr17.12.
PE Ratio
MELHUS SPAREBANK has a trailing twelve months price to earnings ratio of 9.4. Meaning, the purchaser of the share is investing kr9.4 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.56%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 17, 2023, the estimated forward annual dividend rate is 11 and the estimated forward annual dividend yield is 6.88%.
Yearly Top and Bottom Value
MELHUS SPAREBANK’s stock is valued at kr161.00 at 21:20 EST, under its 52-week high of kr177.00 and above its 52-week low of kr151.00.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 40.1% and 18.8%, respectively.
Moving Average
MELHUS SPAREBANK’s worth is above its 50-day moving average of kr158.32 and higher than its 200-day moving average of kr160.94.
More news about MELHUS SPAREBANK.
4. ITERA (ITERA.OL)
7.1% sales growth and 86.07% return on equity
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.76.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 15.26. Meaning, the purchaser of the share is investing kr15.26 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 86.07%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.5%, now sitting on 854.94M for the twelve trailing months.
Yearly Top and Bottom Value
ITERA’s stock is valued at kr11.60 at 21:20 EST, way below its 52-week high of kr16.50 and way higher than its 52-week low of kr10.50.
Moving Average
ITERA’s worth is under its 50-day moving average of kr11.61 and way below its 200-day moving average of kr13.52.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Oct 31, 2023, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 2.59%.
More news about ITERA.
5. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 16.03% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 23.2. Meaning, the purchaser of the share is investing kr23.2 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the ongoing quarter and 6.6% for the next.
More news about VISTIN PHARMA.
